• Issue

    HemaSphere: Volume 8, Issue 10

    October 2024
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • First Published: 07 October 2024

ARTICLE

Open Access

Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemia

Marion Larue,  Myriam Labopin,  Thomas Schroeder,  Xiao-jun Huang,  Igor W. Blau,  Johannes Schetelig,  Arnold Ganser,  Rose-Marie Hamladji,  Wolfgang Bethge,  Nicolaus Kröger,  Gerard Socié,  Urpu Salmenniemi,  Henrik Sengeloev,  Bhagirathbhai Dholaria,  Bipin N. Savani,  Arnon Nagler,  Fabio Ciceri,  Mohamad Mohty, 
  • First Published: 22 October 2024

EDITORIAL

Open Access

Casting light on the national mission to eliminate sickle cell disease in India

Frédéric B. Piel,  Roshan Colah,  Dipty L. Jain, 
  • First Published: 19 October 2024

ARTICLE

Open Access

Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study

Gian Matteo Rigolin,  Pier Paolo Olimpieri,  Valentina Summa,  Simone Celant,  Lydia Scarfò,  Maria Pia Ballardini,  Antonio Urso,  Silvia Gambara,  Francesco Cavazzini,  Paolo Ghia,  Antonio Cuneo,  Pierluigi Russo, 
  • First Published: 08 October 2024
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study

EDITORIAL

Open Access

Promoting and supporting leadership in hematology departments

Roch Houot,  Emmanuel Gyan, 
  • First Published: 17 October 2024

HemaTopics

Open Access

Overcoming a T-ALL order: A comprehensive study linking genomics to clinical outcomes

Yizhou Huang,  Charles E. de Bock, 
  • First Published: 13 October 2024

ARTICLE

Open Access

Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells

Romane Durand,  Céline Bellanger,  Géraldine Descamps,  Christelle Dousset,  Sophie Maïga,  Jennifer Derrien,  Laura Thirouard,  Louise Bouard,  Hélène Asnagli,  Philip Beer,  Andrew Parker,  Patricia Gomez-Bougie,  Marie-Claire Devilder,  Philippe Moreau,  Cyrille Touzeau,  Agnès Moreau-Aubry,  David Chiron,  Catherine Pellat-Deceunynck, 
  • First Published: 08 October 2024
Combined inhibition of CTPS1 and ATR is a metabolic vulnerability in p53-deficient myeloma cells

LETTER

Open Access

The changing influence of neighborhood socioeconomic status on long-term survival in diffuse large B-cell lymphoma patients: A German metropolitan case-control study spanning over three decades

Susanne Ghandili,  Judith Dierlamm,  Carsten Bokemeyer,  Henrik Kusche,  Frederik Peters, 
  • First Published: 08 October 2024

ARTICLE

Open Access

Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL

Alfredo Rivas-Delgado,  Cristina López,  Guillem Clot,  Ferran Nadeu,  Marta Grau,  Gerard Frigola,  Jan Bosch-Schips,  Josefine Radke,  Naveed Ishaque,  Miguel Alcoceba,  Gustavo Tapia,  Luis Luizaga,  Carmen Barcena,  Nicholas Kelleher,  Neus Villamor,  Tycho Baumann,  Ana Muntañola,  Juan M. Sancho-Cia,  Alejandro M. García-Sancho,  Eva Gonzalez-Barca,  Estella Matutes,  Jordi A. Brito,  Kennosuke Karube,  Itziar Salaverria,  Anna Enjuanes,  Stefan Wiemann,  Frank L. Heppner,  Reiner Siebert,  Fina Climent,  Elías Campo,  Eva Giné,  Armando López-Guillermo,  Silvia Beà, 
  • First Published: 07 October 2024
Open Access

Safe and potent anti-CD19 CAR T-cells with shRNA-IL-6 gene silencing element in patients with refractory or relapsed B-cell acute lymphoblastic leukemia

Jin-Feng Ma,  Jia-Wei Yan,  Mei-Jing Liu,  Chun-Long Yan,  Xiao-Wen Tang,  Hui-Ying Qiu,  Miao Miao,  Yue Han,  Li-Min Li,  Li-Qing Kang,  Nan Xu,  Zhou Yu,  Jing-Wen Tan,  Hong-Jia Zhu,  Xu Jia,  Zhi-Zhi Zhang,  Miao Wang,  Hai-Ping Dai,  Lei Yu,  Sheng-Li Xue,  De-Pei Wu,  Wen-Jie Gong, 
  • First Published: 07 October 2024

ERRATUM

Open Access

Correction to “Single-cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes”

  • First Published: 07 October 2024